Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 1
-10%
portes grátis
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 1
Biology and Pathophysiology
Nagaraju, Ganji Purnachandra; Peela, Sujatha
Elsevier Science & Technology
02/2022
386
Dura
Inglês
9780323988063
15 a 20 dias
1200
Descrição não disponível.
1. Cell origin, biology and pathophysiology hepatocellular carcinoma2. Tumor microenvironment in HCC3. Role of endoplasmic reticulum stress and unfolded protein response (UPR) in the onset and progression of hepatocellular carcinoma4. Effect of cirrhosis and hepatitis on the prognosis of hepatocellular carcinoma5. The role of cellular necrosis in hepatocellular carcinoma6. Tyrosine kinases: their role in hepatocellular carcinoma7. Mitochondrial metabolism in the progression of hepatocellular carcinoma8. Role of transcription factors in growth and metastasis in hepatocellular carcinoma9. The role of next generation sequencing in HCC progression10. Functional mechanisms of microRNAs and Long non-coding RNAs in hepatocellular carcinoma11. ROS mediated pathways: Potential role in liver cancer biology and therapy12. Telomerase in hepatocellular carcinoma13. Exosomes role in hepatocellular carcinoma progression and metastasis. An update on the diagnosis of liver cancer14. A review of chemokines in HCC
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
?Aflatoxin; Aflatoxin B1; Air pollutants; Biogenesis; Biosynthetic mechanism; CTNNB1; Cancer diagnosis; Cancer metabolism; Cancer stem-like cells (CSCs); Cancer treatment; Carcinogenesis; Carcinoma; Chemotherapy; Cholangiocarcinoma; CircRNA; Composition; DNA; Diagnosis; ER stress; Epigenetics; Exosomes; G protein-coupled receptor; Gene alterations; Gene delivery system; Gene therapy; Genetic insights; Glutamine; HBx protein; HCC; HCV core protein; Heavy metals; Hepatectomy; Hepatic carcinoma; Hepatitis; Hepatitis B virus; Hepatitis B virus (HBV); Hepatitis C virus; Hepatitis C virus (HCV); Hepatitis virus; Hepatocellular cancer; Hepatocellular carcinoma; Hepatocellular carcinoma (HCC); Hepatocytes; Heterogeneity; IRE1; Inflammation; Instability; Liver; Liver cancer; Liver cirrhosis; Liver transplantation; LncRNAs; Metabolic reprogramming; Metabolism; Metastasis; MiRNA; MiRNAs; MicroRNA; Mitochondria; Mutations; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Noncoding RNA; Oncogenic drivers; Organic pollutants; PERK; Particulate matter; Pathogenesis; Polymorphisms; Progenitor cells; Prognosis; Progression; Prostanoid receptors; RNA; Radiation therapy; Reactive oxygen species; Reverse transcriptase; Risk factors; Signaling; Signaling pathways; Succinate dehydrogenase; Surgical resection; TP53; Telomerase; Therapeutic targeting; Treatment; Tumor microenvironment; Tumor suppressor; UPR
1. Cell origin, biology and pathophysiology hepatocellular carcinoma2. Tumor microenvironment in HCC3. Role of endoplasmic reticulum stress and unfolded protein response (UPR) in the onset and progression of hepatocellular carcinoma4. Effect of cirrhosis and hepatitis on the prognosis of hepatocellular carcinoma5. The role of cellular necrosis in hepatocellular carcinoma6. Tyrosine kinases: their role in hepatocellular carcinoma7. Mitochondrial metabolism in the progression of hepatocellular carcinoma8. Role of transcription factors in growth and metastasis in hepatocellular carcinoma9. The role of next generation sequencing in HCC progression10. Functional mechanisms of microRNAs and Long non-coding RNAs in hepatocellular carcinoma11. ROS mediated pathways: Potential role in liver cancer biology and therapy12. Telomerase in hepatocellular carcinoma13. Exosomes role in hepatocellular carcinoma progression and metastasis. An update on the diagnosis of liver cancer14. A review of chemokines in HCC
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
?Aflatoxin; Aflatoxin B1; Air pollutants; Biogenesis; Biosynthetic mechanism; CTNNB1; Cancer diagnosis; Cancer metabolism; Cancer stem-like cells (CSCs); Cancer treatment; Carcinogenesis; Carcinoma; Chemotherapy; Cholangiocarcinoma; CircRNA; Composition; DNA; Diagnosis; ER stress; Epigenetics; Exosomes; G protein-coupled receptor; Gene alterations; Gene delivery system; Gene therapy; Genetic insights; Glutamine; HBx protein; HCC; HCV core protein; Heavy metals; Hepatectomy; Hepatic carcinoma; Hepatitis; Hepatitis B virus; Hepatitis B virus (HBV); Hepatitis C virus; Hepatitis C virus (HCV); Hepatitis virus; Hepatocellular cancer; Hepatocellular carcinoma; Hepatocellular carcinoma (HCC); Hepatocytes; Heterogeneity; IRE1; Inflammation; Instability; Liver; Liver cancer; Liver cirrhosis; Liver transplantation; LncRNAs; Metabolic reprogramming; Metabolism; Metastasis; MiRNA; MiRNAs; MicroRNA; Mitochondria; Mutations; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Noncoding RNA; Oncogenic drivers; Organic pollutants; PERK; Particulate matter; Pathogenesis; Polymorphisms; Progenitor cells; Prognosis; Progression; Prostanoid receptors; RNA; Radiation therapy; Reactive oxygen species; Reverse transcriptase; Risk factors; Signaling; Signaling pathways; Succinate dehydrogenase; Surgical resection; TP53; Telomerase; Therapeutic targeting; Treatment; Tumor microenvironment; Tumor suppressor; UPR
